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Background: Urgent referral for suspected cancer was implemented in Denmark on 1 April 2008 to reduce the
secondary care interval (i.e. the time interval from the general practitioner’s first referral of a patient to secondary
health care until treatment is initiated). However, knowledge about the association between the secondary care
interval and urgent referral remains scarce. The aim of this study was to analyse how the secondary care interval
changed after the introduction of urgent referral.
Methods: This was a retrospective population-based study of 6,518 incident cancer patients based on
questionnaire data from the patients’ GPs. Analyses were stratified with patients discharged from Vejle Hospital in
one stratum and patients from other hospitals in another because Vejle Hospital initiated urgent referrals several
years prior to the national implementation. Further, analyses were stratified according to symptom presentation and
whether or not the GP referred the patient on suspicion of cancer. Symptom presentation was defined as with or
without alarm symptoms based on GP interpretation of early symptoms.
Results: The median secondary care interval decreased after the introduction of urgent referral. Patients discharged
from Vejle Hospital tended to have shorter secondary care intervals than patients discharged from other hospitals.
The strongest effect was seen in patients with alarm symptoms and those who were referred by their GP on
suspicion of cancer. Breast cancer patients from Vejle Hospital experienced an even shorter secondary care interval
after the national introduction of urgent referrals.
Conclusion: Urgent referral had a positive effect on the secondary care interval, and Vejle Hospital remarkably
managed to shorten the intervals even further. This finding indicates that the shorter secondary care intervals not
only result from the urgent referral guidelines, but also involve other factors.
Keywords: Denmark, Early detection of cancer, Family practice, Health services administrationBackground
The lower cancer survival rates in Denmark than in the
other Nordic countries and many European countries have
been the focus of much attention since the beginning of
this century [1-4]. Studies have indicated that part of the
explanation is that Danish cancer patients seem to be at a* Correspondence: mette.bach.larsen@alm.au.dk
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reproduction in any medium, provided the ormore advanced stage of disease than patients in the other
Nordic countries when treatment is initiated [5,6]. Their
diagnosis and treatment may be delayed due to prolonged
diagnostic and treatment intervals, defined as the period
of time from first cancer symptom until diagnosis and
treatment [7]. The consequences of prolonged diagnostic
and treatment intervals have long been a controversial
issue [8,9], but a recent study suggested a plausible explan-
ation for disparities among previous results and showed
that a longer diagnostic interval was associated with in-
creased mortality among colorectal cancer patients [10].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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care to treatment may be referred to as the secondary care
interval [7]. A long secondary care interval was docu-
mented in Denmark in 2007 [11-13], which directed polit-
ical attention to the waiting lists in the Danish health care
sector and made the Danish government and the Danish
regions (who own and run the hospitals) launch a new
diagnostic strategy that classified cancer as an acute condi-
tion. This marked the beginning of a re-organisation of
the cancer care pathway in Denmark [14].
The Danish government launched its second cancer
plan in 2005, which prescribed the use of a standardised
pathway from cancer suspicion until treatment [15]. In the
summer of 2007, the government decided to implement at
a national level the urgent referral pathway which had been
successfully pursued at regional level at Vejle Hospital since
the late 90s. The principle of urgent referral was formally
introduced for breast, lung, colorectal and head and neck
cancers on a nationwide basis on 1 April 2008. Gynaeco-
logical cancers followed on 1 August 2008 and haemato-
logical cancers on 1 September 2008. By 2010, the urgent
referral scheme had been introduced for 34 different can-
cers [16]. Urgent referral consists of a set of standardised
procedures aiming at offering patients the optimal diagnos-
tic process and rapid treatment [15].
In Denmark, general practitioners (GPs) serve as gate-
keepers to secondary health care. For urgent referrals to
work, the GPs must suspect a specific type of cancer on
the basis of a predetermined set of alarm symptoms. How-
ever, one study has shown that only approx. 50% of all
cancer patients present with typical alarm symptoms in
general practice [17]. This may be explained by the fact
that alarm symptoms of cancer are difficult to define and
that symptoms traditionally considered as alarm symp-
toms (e.g. rectal bleeding, lumps or haemoptysis) often
have positive predictive values of less than 5% [18]. Inter-
national experience has even indicated that urgent refer-
rals may have adverse effects on waiting times for patients
without alarm symptoms [19,20].
Thus, urgent referral was introduced nationally
under the assumption that the secondary care interval
would be reduced. However, knowledge about the ac-
tual association between the secondary care interval
and urgent referrals is scarce. Therefore, the aim of
this study was to analyse how the secondary care inter-
val changed, in general and at Vejle Hospital in par-
ticular, after the introduction of urgent referral for
specific types of cancer.
Method
Study design and setting
This population-based observational study was conducted
among incident cancer patients in the Central Denmark
Region and the Region of Southern Denmark. The tworegions in combination have approx. 2.4 million residents
(44% of the Danish population) and approx. 14,000 new
cancer cases are diagnosed each year.
Vejle Hospital is situated in the Region of Southern
Denmark and the hospital’s oncology department con-
stitutes one of six Danish cancer centres. The oncology
department performs 38,000 outpatient consultations
per year, whereas inpatient bed days amount to 7,500
per year.
Denmark’s publicly funded healthcare system provides
free access to general practice and hospital care. More
than 98% of the Danish citizens are registered with a GP.
Danish GPs keep electronic medical records of their pa-
tients, including hospital discharge letters.
Inclusion procedure
Each hospital admission and outpatient visit in
Denmark is coded and stored in regional patient-
administrative systems, which feed the National Patient
Register [21]. Patients were included from the patient
administrative systems on the basis of their discharge
date and diagnosis and if labelled with the additional
code AZCA1, which indicates that the cancer was
reported for the first time by the department [22]. Both
outpatients and patients dying under admission are reg-
istered with a discharge date. Patients were excluded if
already registered on a national list including all cancer
diagnoses from 1994 to 30 September 2007, which was
extracted from the National Patient Registry. This list
was updated monthly by adding included patients. The
monthly inclusion continued for one year from 1 Octo-
ber 2007 and constitutes Sample 1 of the study popula-
tion. After the study period ended, it became clear that
some of the eligible patients were excluded for two
main reasons. First, some of the patients were registered
later than one month after the diagnosis and were
missed as the inclusion procedure only included one
month back. Second, the AZCA1 code was applied in an
unsystematic way causing inclusion errors. Therefore, add-
itional inclusion was performed in October 2009 by fol-
lowing the same procedure as Sample 1, except that the
entire study period was covered at once and the AZCA1
code was left out as an inclusion criterion (Sample 2). Pa-
tients were excluded from Sample 2 if already included in
Sample 1. Thus, the total study population consists of
Sample 1 and Sample 2 (Figure 1).
Data collection
The GP questionnaire was developed based on litera-
ture and research experience gained from prior studies
of patients’ diagnostic pathways [23]. For patients from
Sample 1, the GPs were sent a questionnaire within a
month after the patients were diagnosed. For patients
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GP response rate 
6,746/7,908=85.3%
GP response rate 
3,516/4,761=73.9%
Total GP response rate 
10,262/12,669=81.0%
Excluded for analyses: N=2,025
Diagnostic pathway not initiated 
by GP: n= 1,326, no information on 
secondary care interval: n=699 
Study population
N=6,518
Figure 1 Flowchart of patient inclusion.
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date of their first referral of the patient to secondary
health care and the date of treatment start based on
their medical records and discharge letters.
The GPs also stated whether the diagnostic pathway
was initiated in general practice, whether they regarded
the initial symptoms as alarm symptoms of cancer and
whether they clearly indicated cancer suspicion in the
first referral to secondary health care. Alarm symptoms
of cancer were not defined in the questionnaire, but the
GPs were guided by examples of unexpected weight
loss, bleeding, continuous coughing and lumps.
Non-responding GPs received a reminder after three
weeks. The GPs were remunerated for their participation
(approx. 16 €).Outcome measures
Estimation of the secondary care interval was primarily
based on data obtained from the GP questionnaires. The
GPs provided information on when they initially referred
the patients to secondary health care and stated the date
of treatment based on their medical records.
However, for 2,024 (31.1%) patients, the GPs did not
provide complete information on the secondary care inter-
val, mainly because the GPs had received the question-
naire before obtaining information about treatment start.
For those patients, we estimated the secondary care inter-
val on the basis of the patients’ hospital admission date.
This approximation systematically underestimated the
interval as the median GP-reported secondary care interval
was 40 days (IQI: 22; 74 days) compared with the 31-day
(IQI: 14; 66 days) interval obtained when the interval was
calculated on the basis of the patients’ date of admission.
Specific analyses were performed for patients diagnosed
before or after the implementation of urgent referral for
suspected cancer if they were admitted to hospital before
or after 1 April 2008, respectively. Patients were further di-
vided into groups according to whether the GPs interpreted
the initial symptoms as alarm symptoms of cancer and
whether cancer suspicion was clearly mentioned in the first
referral. Finally, patients were grouped according to dis-
charging hospital with Vejle Hospital in one group and
other hospitals in another.
Analyses
Data analyses were restricted to include only patients
with a diagnostic pathway initiated in primary care since
the pathway of interest in the present study was the part
where GPs refer patients to further diagnostic work-up
in secondary care (main route to diagnosis of cancer in
Denmark [23]).
The secondary care interval is presented as medians
with interquartile intervals (IQIs) because data were not
normally distributed. The Wilcoxon rank sum test was
used to test for differences before and after the national
introduction of urgent referral for suspected cancer.
Trends in monthly median differences were identified
by non-parametric trend tests across ordered groups.
To test for differences between groups, the Wilcoxon
rank sum test was used. Estimates were given with 95%
confidence intervals (95%CI) when relevant. Analyses
were conducted using Stata 11.2 [24].
Ethics approval
According to the Scientific Ethics Committee in the
former County of Aarhus, the project did not need ap-
proval by the Danish Biomedical Research Ethics Com-
mittee System. The study was approved by the Danish
Data Protection Agency and the Danish National Board
of Health.
Table 1 Patient characteristics of those discharged from





All 5,743 (88.1) 775 (11.9) p-value
Sex
Male 2,917 (50.8) 268 (34.6) <0.001
Female 2,826 (49.2) 507 (65.4)
Age (years)
18-49 690 (12.0) 124 (16.0) <0.001
50-69 2,656 (46.3) 294 (51.4)
70+ 2,397 (41.7) 253 (32.7)
Cancer diagnosis
Breast 772 (13.4) 260 (33.6) <0.001
Colorectal 842 (14.7) 96 (12.4) 0.090
Lung 712 (12.4) 113 (14.6) 0.086
Head and Neck 165 (2.4) 9 (1.2) 0.006
Prostate 746 (13.0) 19 (2.5) <0.001
Other 2,506 (43.6) 278 (35.9) <0.001
Alarm symptoms
Yes 3,541 (62.7) 519 (67.8) 0.007
No 2,104 (37.3) 247 (32.3)
Cancer suspicion
Yes 3,156 (63.6) 435 (66.4) 0.154
No 1,809 (36.4) 220 (33.6)
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A total of 12,669 cancer patients were screened for in-
clusion into the study (Sample 1: n = 7,908; Sample 2:
n = 4,761), and a GP questionnaire was completed for
10,262 (81.0%). Based on the questionnaires, a total of
1,719 (16.8%) patients were excluded for not meeting
the inclusion criteria. Of the remaining 8,543 patients
eligible for inclusion, the diagnostic pathway was not
initiated through the GP for 1,326 of the (15.5%) pa-
tients. They were excluded together with 699 (8.2%)
patients for whom we had no information on the sec-
ondary care interval. Thus, a total of 6,518 (59.5%) pa-
tients were included in the analyses (Figure 1).
Patients with non-responding GPs were more likely to
be older males, fewer had breast and lung cancers and
more had prostate cancer. No statistically significant
difference was observed in response rate from GPs with
patients discharged from Vejle Hospital compared with
other hospitals. Patients discharged from Vejle Hospital
were statistically significantly more likely to be females,
younger and diagnosed with breast cancer. Secondary
care intervals were statistically significantly more often
incomplete in other hospitals than Vejle Hospital, in pa-
tients without alarm symptoms and in cases when the
GPs did not indicate cancer suspicion in the referral pa-
pers (Table 1). No differences were observed in the
proportion of incomplete secondary care intervals before
and after the introduction of urgent referral for suspected
cancer (data not shown).
The secondary care interval before and after the
introduction of urgent referral for suspected cancer
The secondary care interval was statistically significantly
shorter at other hospitals after the national introduction
of urgent referral for suspected cancer than before the
introduction. Breast cancer patients saw the largest re-
duction (10 days), whereas no statistically significant re-
duction was found for head and neck cancer patients. At
Vejle Hospital, the improvement was statistically signifi-
cant only for breast cancer (eight days) (Table 2).
At other hospitals than Vejle, the median secondary
care interval decreased regardless of whether the GP in-
dicated cancer suspicion or alarm symptoms of cancer.
At Vejle Hospital this was only the case if the GPs indi-
cated cancer suspicion or alarm symptoms in their re-
ferral documents (Table 2).
For diagnoses where the urgent referral policy was intro-
duced after the study period, the secondary care interval
did not decrease significantly (other diagnosis, Table 2).
Trends in secondary care interval by month
The median secondary care interval for the study period
for all patients discharged from Vejle Hospital was
29 days (IQI: 18; 50 days) compared with 39 days (IQI:20; 74 days) for patients discharged from other hospitals.
For both Vejle Hospital and other hospitals, a statisti-
cally significantly decreasing trend was observed (Vejle:
p = 0.007, other: p < 0.001). Stratified by diagnosis, the
decreasing trend in the median secondary care interval
was statistically significant for breast cancer (p < 0.001),
colorectal cancer (p < 0.001) and lung cancer (p = 0.009)
at other hospitals, but only for breast cancer at Vejle
Hospital (p < 0.001). No statistically significant decreasing
trend was observed for other cancer diagnoses. Further, a
tendency towards a decrease in the secondary care interval
was seen for other hospitals than Vejle Hospital before the
introduction of urgent referral. This tendency was statisti-
cally significant for colorectal cancer (Figure 2).
Discussion
Main findings
The median secondary care interval decreased overall after
the introduction of urgent referrals for suspected cancer.
With a decrease of 10 days, breast cancer patients saw the
largest decrease. Studies have shown that breast cancer
patients with treatment delays of three months or more
had a lower 5-year survival rate than patients with shorter
Table 2 The median secondary care interval (days) before and after urgent referral for suspected cancer
Other hospitals Vejle hospital
Before urgent
referral n = 3,131
After urgent
referral n = 2,612
Before urgent
referral n = 387
After urgent
referral n = 388
Median (IQI) Median (IQI) p-value Median (IQI) Median (IQI) p-value
All 42 (22; 80) 35 (18; 67) <0.001 30 (20; 50) 26 (15; 51) 0.020
Sex
Male 46 (23; 90) 40 (20; 80) <0.001 32 (20; 63) 29 (17; 68) 0.362
Female 39 (21; 69) 32 (16; 57) <0.001 29 (20; 45) 26 (15; 48) 0.036
Age (years)
18-49 41 (21; 73) 29 (15; 61) 0.003 35 (18; 61) 25 (14; 39) 0.132
50-69 53 (30; 98) 45 (22; 81) <0.001 29 (20; 43) 26 (17; 50) 0.408
70+ 41 (21; 77) 36 (18; 68) <0.001 33 (22; 56) 27 (15; 52) 0.062
Cancer diagnosis
Breast 33 (21; 56) 23 (15; 38) <0.001 28 (20; 40) 21 (13; 33) <0.001
Lung 37 (21;64) 33 (16; 53) 0.008 31 (20; 41) 29 (23; 65) 0.392
Colorectal 38 (22; 71) 30 (18; 53) <0.001 32 (23; 46) 26 (18; 37) 0.068
Head and neck* 39 (22; 64) 37 (17; 66) 0.443
Prostate* 72 (37; 141) 67 (31; 104) 0.028
Other 42 (19; 80) 40 (18; 76) 0.358 30 (17; 64) 31 (16; 70) 0.842
Alarm symptoms
Yes 38 (21; 70) 33 (16; 58) <0.001 32 (22; 49) 27 (18; 44) 0.025
No 49 (26; 96) 42 (20; 86) <0.001 41 (27; 89) 36 (18; 77) 0.097
Cancer suspicion
Yes 36 (20; 67) 30 (16; 56) <0.001 30 (21; 44) 22 (15; 37) 0.001
No 52 (27; 98) 46 (23; 89) 0.018 51 (30; 91) 43 (28; 84) 0.259
*The number of cases at Vejle Hospital was too small to produce precise results on head and neck cancer (n = 9) and prostate cancer (n = 19).
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may not result in reduced mortality in general, but the
patients who waited the longest (e.g. the 75 percentile
was 74 days at other hospitals than Vejle before the na-
tional introduction of the urgent referral guidelines)
may have gained more from the introduction of the ur-
gent referral guidelines. Finally, there may be other ben-
efits valued by patients as well as professionals.
Both before and after the national introduction of the
urgent referral guidelines, patients had a shorter sec-
ondary care interval in cases where initial symptoms
were categorised as alarm symptoms by the GP or the
GP indicated cancer suspicion in the referral docu-
ments. Obviously, patients with a clearer pathological
picture are easier to diagnose. This also supports the
assumption that the GP’s symptom interpretation and
reaction to suspicion of cancer is instrumental in short-
ening the secondary care interval for cancer patients.
However, at other hospitals than Vejle, the secondary
care interval also decreased for patients with no indica-
tion of cancer suspicion and no alarm symptoms, indi-
cating improved performance of the system as a whole.The tendency towards a decrease in the secondary care
interval at other hospitals seemed to appear when the
need for such decrease was officially recognised, i.e. be-
fore the formal implementation of the urgent referral
guidelines. Furthermore, it should be noted that Vejle
Hospital was able to reduce its secondary care intervals
even further when the introduction of the urgent referral
system was introduced at national level.
The study design does not allow any determination of
causation. The fact that diagnoses without urgent refer-
rals did not decrease statistically significant after the
introduction of urgent referrals indicates that the de-
creasing secondary care intervals could be related to the
introduction of urgent referrals. On the contrary, the fact
that Vejle Hospital actually managed to decrease their sec-
ondary care intervals, also for patients with no indication
of cancer suspicion in the referrals from their GP, indicates
that the decrease is also related to other factors.
Strengths and weaknesses
Selection bias in this study was induced during the ini-
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Figure 2 Monthly secondary care intervals (median days with interquartile intervals). Urgent referral for suspected cancer was introduced
in April 2008.
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patients. However, this may have induced information
bias since the GPs of Sample 1 received the question-
naire within one month after diagnosis, while the GPs of
Sample 2 received the questionnaire between one and
two years after diagnosis. GP recall bias could influence
the secondary care interval and the categorisation of pa-
tients according to initial symptom presentation and
cancer suspicion for the first referral to secondary health
care. Recall bias is not considered to have much impact
on length of secondary care interval nor on number of
suspected cancer referrals since the GPs have access to
this information through the patients’ electronic medical
records, which are considered robust data sources. Apart
from guiding the GPs with examples of alarm symptoms,
it was not specified precisely which symptoms should be
categorised as alarm symptoms. Thus, the interpretation
of the same symptom could differ among GPs. This
source of information bias is not considered to be major
for two reasons. First, alarm symptoms of cancer are not
clear-cut and will therefore be influenced by individual
GP interpretation. Second, alarm symptoms of cancer
are known to the GPs so that if they do suspect cancer
such symptoms (e.g. rectal bleeding) will be categorised
as alarm symptoms. Another possible source of informa-
tion bias is the retrospective design of the study. The GP
knows that the patient has cancer when filling out the
questionnaire which may influence the answers. However,
it would be costly to set up a prospective study given the
few cancer patients diagnosed by each GP every year. Fur-
thermore, it has been shown that the GPs are willing to
answer these questions because they see a learning poten-
tial in going through the care pathway retrospectively [26].
In conclusion, even though the retrospective design may
be a source of bias, the data are considered a reliable foun-
dation for the analyses.
GP-induced selection bias may have occurred if patients
of non-responding GPs had a different secondary care
interval than patients of responding GPs. If GPs with a
longer doctor interval (time from the patient’s first contact
with the GP until first cancer-related investigation) tended
to be more reluctant to respond, this could lead to shorter
secondary care intervals. This bias may therefore lead us
to make a type II error by underestimating the association
between the introduction of the urgent referral guidelines
and the secondary care interval.
The considerable sample size strengthens the statis-
tical precision of this study. We did not have complete
information on the secondary care interval for almost
one third of the patients due to missing treatment dates.
We used the date of admission in these cases, which in-
troduced a systematic underestimation of the secondary
care interval. Since more patients in other hospitals than
Vejle as well as patients without alarm symptoms andwithout indication of cancer suspicion had incomplete
secondary care intervals, we underestimated the secondary
care interval for patients with the longest secondary care
interval, and this may have provided absolute minimum
differences. Since we were still able to detect considerable
changes, we have found that this bias was not considerable
enough to significantly alter our conclusions.
No information is available on who were actually re-
ferred urgently after the introduction of urgent referral.
The GPs’ reported data on whether patients presented
with alarm symptoms and clearly indicated cancer suspi-
cion in connection with first referral are therefore our
best sources of information for determining whether the
patients were regarded as urgent or not. However, since
the study included a period before and a period after the
urgent referral was implemented, it is meaningful to
compare the GPs’ assessment of the initial symptoms
and whether or not the GPs indicated cancer suspicion
in their referrals to secondary health care since we have
this information for both periods.
The conclusions of this study are considered generalis-
able to other regions in Denmark and to other health care
systems involving GPs serving as gatekeepers to secondary
health care. The possible impact of the urgent referral will
depend on the local context.Findings in relation to other studies
The overall median secondary care interval of 42 days
(IQI: 22; 80 days) for other hospitals than Vejle Hospital
before the introduction of urgent referrals is fairly consist-
ent with the results from another Danish study from 2005,
which reported a secondary care interval of 46 days (IQI:
26;78) [13]. This study used the same definition of the sec-
ondary care interval and also collected data by use of
questionnaires sent to the GPs. A comparison of our re-
sults with the findings of a recent study by the Danish
National Board of Health shows that the secondary care
intervals reported in our study were shorter than those
previously reported, except for colorectal cancer [12]. The
National Board of Health counted the days from the re-
ceipt of referrals at the hospitals, whereas we measured
from the day on which the referrals were forwarded by the
GPs. Furthermore, the National Board of Health counted
the days until the patients gave consent to treatment,
whereas we included the time until treatment was actually
initiated. Further, we included the GPs’ suspicion of can-
cer and having noted so in the referral documents. The
present study was hence able to demonstrate the im-
portance of the referral process and the GPs’ know-
ledge, awareness and action. In addition, we were able
to compare Vejle Hospital with other hospitals and
identify aspects highlighting the possible impact of ur-
gent referral on time to treatment.
Larsen et al. BMC Health Services Research 2013, 13:348 Page 8 of 9
http://www.biomedcentral.com/1472-6963/13/348In other healthcare settings, studies have reported a
direct, negative impact on the length of the secondary
care interval for non-urgent patients from the introduc-
tion of urgent referral for suspected cancer [19,27-29].
However, we saw no indication of such major adverse
effect in our data.
Conclusion
The secondary care interval decreased significantly after
the national introduction of urgent referrals for suspected
cancer. Patients with alarm symptoms in general and pa-
tients for whom the GP explicitly stated cancer suspicion
saw the best effects of the urgent referral. Vejle Hospital
remarkably managed to shorten their intervals even fur-
ther. In conclusion, this study indicates that the shorter
secondary care intervals result not only from the urgent
referral policy, but also other factors are involved.
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